Alexsandro Tavares Figueiredo-Junior

Dr. Alexsandro Tavares Figueiredo-Junior

Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Alexsandro Tavares Figueiredo-JuniorAlexsandro Tavares Figueiredo-Junior
Alexsandro Tavares Figueiredo-Junior
Samuel ValencaSamuel Valenca
Samuel Valenca
PFPriscilla Finotelli
Priscilla Finotelli
FAFrancisca de Fátima dos Anjos
Francisca de Fátima dos Anjos
LBLycia de Brito-Gitirana
Lycia de Brito-Gitirana
Manuella LanzettiManuella Lanzetti
Manuella Lanzetti
The use of annatto pigments has been evaluated as a therapeutic strategy in animal models of several health disorders. Beneficial effects were generally attributed to the inhibition of oxidative stress. Bixin is the main pigment present in annatto seeds and has emerged as an important scavenger of reactive oxygen (ROS) and nitrogen species (RNS). However, this carotenoid is highly hydrophobic, affecting its therapeutic applicability. Therefore, bixin represents an attractive target for nanotechnology to improve its pharmacokinetic parameters. In this study, we prepared bixin nanoparticles (npBX) and evaluated if they could prevent pulmonary inflammation and oxidative stress induced by cigarette smoke (CS). C57BL/6 mice were exposed to CS and treated daily (by gavage) with different concentrations of npBX (6, 12 and 18%) or blank nanoparticles (npBL, 18%). The negative control group was sham smoked and received 18% npBL. On day 6, the animals were euthanized, and bronchoalveolar lavage fluid (BALF), as well as lungs, were collected for analysis. CS exposure led to an increase in ROS and nitrite production, which was absent in animals treated with npBX. In addition, npBX treatment significantly reduced leukocyte numbers and TNF-α levels in the BALF of CS-exposed mice, and it strongly inhibited CS-induced increases in MDA and PNK in lung homogenates. Interestingly, npBX protective effects against oxidative stress seemed not to act via Nrf2 activation in the CS + npBX 18% group. In conclusion, npBX prevented oxidative stress and acute lung inflammation in a murine model of CS-induced acute lung inflammation.

12 September 2020 in Applied Nanoscience
Verified
Journal Article
Closed access
PDF file
Alexsandro Tavares Figueiredo-JuniorAlexsandro Tavares Figueiredo-Junior
Alexsandro Tavares Figueiredo-Junior
FAFrancisca de Fátima dos Anjos
Francisca de Fátima dos Anjos
FBFrancisco das Chagas de Melo Brito
Francisco das Chagas de Melo Brito
VVVICENTE GALBER FREITAS VIANA
VICENTE GALBER FREITAS VIANA
Samuel ValencaSamuel Valenca
Samuel Valenca
PFPriscilla Finotelli
Priscilla Finotelli

8 December 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
HVHelber da Maia Valença
Helber da Maia Valença
EMEvelyn Caribé Mota
Evelyn Caribé Mota
ASAndressa Caetano da Fonseca Andrade Silva
Andressa Caetano da Fonseca Andrade Silva
Alexsandro Tavares Figueiredo-JuniorAlexsandro Tavares Figueiredo-Junior
Alexsandro Tavares Figueiredo-Junior
FGFernanda Verdini Guimarães
Fernanda Verdini Guimarães
JMJoão Alfredo Moraes
João Alfredo Moraes
Obesity is characterized by an imbalance between energy intake and expenditure that triggers abnormal growth of adipose tissues. Dimethyl fumarate (DMF) and its primary active metabolite, monomethyl fumarate (MMF), are Nrf2 activators and have been recognized as strategic antioxidants. This study aimed to evaluate the potential of MMF and DMF to interfere with adipogenesis and obesity, and identify the molecular mechanisms involved. The 3T3-L1 preadipocytes were incubated with differentiation medium (MIX) and simultaneously treated with different concentrations of MMF. In addition, male C57BL/6 mice were fed a standard diet or high-fat/high-sucrose diet (HFHSD) for 16 weeks, during the last 4 of which, they received oral DMF treatment. Exposure to MMF prevented the development of MIX-induced adipogenesis by reducing the expression of transcription factors that drive adipocyte differentiation and by decreasing triglyceride levels. In addition, various antioxidant and anti-inflammatory effects were observed after treatment with MMF as evidenced by the modulation of transcription factor activities and reduction in reactive oxygen species, adipokine, proinflammatory cytokine and resistin levels. In vivo treatment with DMF reduced calorie intake, body weight, and visceral and subcutaneous fat mass in HFHSD mice. Furthermore, DMF administration led to a better glycemic response as well as lower leptin and adiponectin plasma levels in these animals. Our data demonstrate that DMF and its metabolite MMF interfere with adipogenesis and prevent the key features of diet-induced obesity. Considering DMF is already a commercial drug used to treat psoriasis and multiple sclerosis, its pharmacological application for the treatment of obesity and related metabolic disorders holds promise.

5 April 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Alexsandro Tavares Figueiredo-JuniorAlexsandro Tavares Figueiredo-Junior
Alexsandro Tavares Figueiredo-Junior
Bruno Clemente Brandão MarquesBruno Clemente Brandão Marques
Bruno Clemente Brandão Marques
DSDouglas Dos Santos
Douglas Dos Santos
Wesley Leandro GouveiaWesley Leandro Gouveia
Wesley Leandro Gouveia
Raysa Magali Pillpe MezaRaysa Magali Pillpe Meza
Raysa Magali Pillpe Meza
Manuella LanzettiManuella Lanzetti
Manuella Lanzetti
Background: Nrf2 plays a key role in regulating the antioxidant response against oxidative stress. Therefore, it is imperative to examine the advantages of Nrf2 activation by new small molecules capable of inhibiting the Nrf2-Keap1 protein interaction that do not present electrophilic sites, since electrophilic compounds have intrinsic toxicity. The bixin pigment has been used as a form of treatment and prevention of several pathological conditions in animal models since it was described as an Nrf2 activator without electrophilic sites. This study aims to synthetize a soluble derivate KBx (potassium bixinate) and evaluate its ability to activate Nrf2/ARE in a model of exposure to cigarette smoke extract (CSE; in vitro) and intranasal LPS administration (in vivo). Methods: In the in vivo study, C57BL/6 mice were pretreated with 200 mg/kg of KBx (gavage) during 5 consecutive days and then challenged with 60 µg of LPS i.n. for 16 h. Bronchoalveolar lavage was collected to examine cytokines dosage. In the in vitro study, RAW 264.7 macrophages were exposed to CSE and post-treated with KBx to evaluate their ability to revert the redox imbalance caused by the stressor. Results: KBx was characterized using mass spectrometry (433.1778 m/z). KC levels were increased in the LPS group (p = 0.021), and KBx inhibited this (p = 0.001). IL-10 levels were decreased (p = 0.055) in the LPS group that was prevented when pretreated with KBx (p = 0.037). The in vitro study showed KBx to be a more potent derivate of bixin through its ability to intercept ROS formation with three-fold more potency, and it showed an anti-inflammatory propriety by reducing the nuclear translocation of p65 (p < 0.001). Conclusions: In conclusion, these data suggest that KBx was able to activate the Nrf2/ARE pathway and intercept ROS formation induced by CSE and LPS in both in vivo and in vitro studies.

22 September 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
AOAline Pontes De Oliveira
Aline Pontes De Oliveira
Alexsandro Tavares Figueiredo-JuniorAlexsandro Tavares Figueiredo-Junior
Alexsandro Tavares Figueiredo-Junior
PMPriscilla Cristine de Oliveira Mineiro
Priscilla Cristine de Oliveira Mineiro
EMEvelyn Caribé Mota
Evelyn Caribé Mota
CACarolinne Souza de Amorim
Carolinne Souza de Amorim
Manuella LanzettiManuella Lanzetti
Manuella Lanzetti
Chronic obstructive pulmonary disease (COPD) is characterized by chronic pulmonary inflammation and the destruction of the pulmonary parenchyma (emphysema), with only symptomatic treatment available. Molecules with antioxidant and anti-inflammatory properties, such as dimethyl fumarate (DMF), have shown therapeutic potential. This study evaluated the effects of DMF and its metabolite, monomethyl fumarate (MMF), on pulmonary inflammation induced by cigarette smoke (in vitro) and porcine pancreatic elastase (PPE) in mice (in vivo). In vitro, human pulmonary epithelial cells (PC-9) were treated with MMF at concentrations of 10, 30, and 100 µM and exposed to cigarette smoke extract (CSE) to assess cell viability, oxidative stress (ROS), lipid peroxidation, and nitrite production. In vivo, C57BL/6 mice were treated with DMF (30 and 100 mg/kg) during and after the induction of emphysema by PPE. ROS levels, total cell count in bronchoalveolar lavage fluid (BALF), lung histology, and the expression of oxidative stress proteins (SOD1 and HO-1) were analyzed. MMF reduced oxidative stress and lipid peroxidation under in vitro conditions. In vivo, DMF reduced ROS levels, inflammation, and prevented lung damage, such as alveolar enlargement. The expression of SOD1 and HO-1 was modulated by DMF treatment. The results suggest that DMF could be an effective therapeutic alternative for COPD, reducing oxidative stress and inflammation.